DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
Can DCTs Be Both Patient Centric And Financially Efficient For Sites?
While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.
-
Advancing Rare Disease Research With Patient Registries
In this Q&A, “Rare dad” Harsha Rajasimha, Ph.D. of IndoUSrare discusses the current state of rare disease research and explains how patient registries can help propel drug development for rare disease therapies.
DCT TECHNOLOGY RESOURCES
-
Explore how eCOAs will become an effective way to capture data remotely throughout the trial as sponsors shift to decentralized clinical trials.
-
Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.
-
Consider DIA GCP & QA Community Chair Terry Katz’s perspective on repurposing and analyzing EHR data for clinical research.
-
Discover how researchers can design studies with the needs of the patient in mind to promote faster enrollment, high engagement, and the production of more complete and accurate data.
-
Unearth the ways electronic clinical outcome assessment technology is revolutionizing data collection, improving patient experiences, and enhancing trial outcomes.
-
Learn why now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.